What do hormones have to do with aging? What does aging have to do with hormones?

Annals of the New York Academy of Sciences

Volumn 1019, Issue , 2004, Pages 299-308

  Harman, S Mitchell ^a  

^a Kronos Longevity Research Institute   (United States)

Author keywords

Aging; Cell; Damage; Diet; Hormones; Oxidative stress

Indexed keywords

GROWTH HORMONE;

AEROBIC METABOLISM; CELL MEMBRANE; CONFERENCE PAPER; ENDOCRINE DISEASE; ENDOCRINE FUNCTION; GENETIC SUSCEPTIBILITY; HORMONE ACTION; HUMAN; NONHUMAN; PHENOTYPE; SENESCENCE;

EID: 3242731206     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1297.051     Document Type: Conference Paper

References (109)

1. KALLMAN, D.A., C. PLATO & J. TOBIN. 1990. The role of muscle loss in age-related decline in grip strength: a cross-sectional and longitudinal analysis. J. Gerontol. 45: M82-M88.
2. 2 max. J. Appl. Physiol. 65(3): 1147-1151.
3. FRIED, L.P., R.A. KRONMAL, A.B. NEWMAN, et al. 1998. Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA 279(8): 585-592.
4. SHIMOKATA, H., J.D. TOBIN, D.C. MULLER, et al. 1989. Studies in the distribution of body fat: I. Effects of age, sex, and obesity. J. Gerontol. 44: M67-M73.
5. KOHRT, W.M., J.P. KIRWAN, M.A. STATEN, et al. 1993. Insulin resistance in aging is related to abdominal obesity. Diabetes 42: 273-281.
6. FINK, R.I., O.G. KOLTERMAN, J. GRIFFIN & J.M. OLEFSKY. 1983. Mechanisms of insulin resistance in aging. J. Clin. Invest. 71: 1523-1535.
7. WARK, J.D. 1996. Osteoporotic fractures: background and prevention strategies. Maturitas 23(2): 193-207.
8. SCORDAMAGLIA, A., G. CIPRANDI, F. INDIVERI & G.W. CANONICA. 1991. The effect of aging on host defences: implications for therapy. Drugs Aging 1(4): 303-316.
9. HELGASON, A.R., J. ADOLFSSON, P. DICKMAN, et al. 1996. Sexual desire, erection, orgasm, and ejaculatory functions and their importance to elderly Swedish men: a population-based study. Age Ageing 25(4): 285-291.
10. MORLEY, J.E., E. CHARLTON, P. PATRICK, et al. 2000. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 49(9): 1239-1242.
11. KAISER, F.E., S.P. VIOSCA, J.E. MORLEY, et al. 1988. Impotence and aging: clinical and hormonal factors. J. Am. Geriatr. Soc. 36(6): 511-519.
12. BREMNER, W.J. & P.N. PRINZ. 1983. A loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J. Clin. Endocrinol. Metab. 56: 1278-1281.
13. VERMEULEN, A. & J.M. KAUFMAN. 1995. Ageing of the hypothalamo-pituitary-testicular axis in men. Horm. Res. 43(1-3): 25-28.
14. TENOVER, J.S., A.M. MATSUMOTO, S.R. PLYMATE & W.J. BREMNER. 1987. The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: response to clomiphene citrate. J. Clin. Endocrinol. Metab. 65: 1118-1126.
15. HARMAN, S.M., E.J. METTER, J.D. TOBIN, et al. 2001. Longitudinal effects of aging on serum total and free testosterone levels in healthy men: Baltimore Longitudinal Study of Aging. J. Clin. Endocrinol. Metab. 86(2): 724-731.
16. MORLEY, J.E., F.E. KAISER, H.M. PERRY, et al. 1997. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism 46(4): 410-413.
17. SONNTAG, W.E. & J. MEITES. 1988. Decline in GH secretion in aging animals and man. In Regulation of Neuroendocrine Aging, pp. 111-124. Karger. Basel.
18. VITTONE, J., M.R. BLACKMAN, M.J. BUSBY-WHITEHEAD, et al. 1997. Effects of single nightly injections of growth hormone releasing hormone (GHRH 1-29) in healthy elderly men. Metabolism 46: 89-96.
19. CORPAS, E., S.M. HARMAN & M.R. BLACKMAN. 1993. Human growth hormone and human aging. Endocr. Rev. 14: 20-39.
20. O'CONNOR, K.O., T.E. STEVENS & M.R. BLACKMAN. 1996. GH and aging. In Growth Hormone in Adults, pp. 323-366. Cambridge University Press. London/Cambridge/New York.
21. KELIJMAN, M. 1991. Age-related alterations of the growth hormone/insulin-like-growth-factor I axis. J. Am. Geriatr. Soc. 39(3): 295-307.
22. Ho, K.Y., W.S. EVANS, R.M. BLIZZARD, et al. 1987. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J. Clin. Endocrinol. Metab. 64(1): 51-58.
23. O'CONNOR, K.G., J.D. TOBIN, S.M. HARMAN, et al. 1998. Serum levels of insulin-like growth factor-I are related to age and not to body composition in healthy women and men. J. Gerontol. A Biol. Sci. Med. Sci. 53(3): M176-M182.
24. PAVLOV, E.P., S.M. HARMAN, G.R. MERRIAM, et al. 1986. Responses of growth hormone (GH) and somatomedin-C to GH-releasing hormone in healthy aging men. J. Clin. Endocrinol. Metab. 62(3): 595-600.
25. SHIBASAKI, T., K. SHIZUME, M. NAKAHARA, et al. 1984. Age-related changes in plasma growth hormone response to growth hormone-releasing factor in man. J. Clin. Endocrinol. Metab. 58: 212-214.
26. DUDL, R. & J. ENSICK. 1977. Insulin and glucagon relationships during aging in man. Metabolism 26: 33-41.
27. COPELAND, K.C., R.B. COLLETTI, J.D. DEVLIN & T.L. MCAULIFFE. 1990. The relationship between insulin-like growth factor-1, adiposity, and aging. Metab. Clin. Exp. 39: 584-587.
28. DEFRONZO, R.A. 1979. Glucose intolerance and aging: evidence for tissue insensitivity to insulin. Diabetes 28: 1095-1101.
29. FRAEYMAN, N., E. VAN DE VELDE, A. VAN ERMEN, et al. 2000. Effect of maturation and aging on beta-adrenergic signal transduction in rat kidney and liver. Biochem. Pharmacol. 60(12): 1787-1795.
30. KATZ, M.S., E.M. DAX & R.I. GREGERMAN. 1993. Beta adrenergic regulation of rat liver glycogenolysis during aging. Exp. Gerontol. 28(4-5): 329-340.
31. CARVALHO, E., C. RONDINONE & U. SMITH. 2000. Insulin resistance in fat cells from obese Zucker rats - evidence for an impaired activation and translocation of protein kinase B and glucose transporter 4. Mol. Cell. Biochem. 206(1-2): 7-16.
32. LIM, B.O., C.A. JOLLY, K. ZAMAN & G. FERNANDES. 2000. Dietary (n-6) and (n-3) fatty acids and energy restriction modulate mesenteric lymph node lymphocyte function in autoimmune-prone (NZB x NZW)F1 mice. J. Nutr. 130(7): 1657-1664.
33. SONG, L., Y.H. KIM, R.K. CHOPRA, et al. 1993. Age-related effects in T cell activation and proliferation. Exp. Gerontol. 28(4-5): 313-321.
34. SONG, L.J., J.E. NAGEL, F.J. CHREST, et al. 1992. Comparison of CD3 and CD2 activation pathways in T cells from young and elderly adults. Aging (Milano) 4(4): 307-315.
35. ARKING, R. 1998. Biology of Aging: Observations and Principles. Second edition. Sinauer Associates. Sunderland, MA.
36. CUTLER, R.G. 1976. Nature of aging and life maintenance processes. In Interdisciplinary Topics in Gerontology, pp. 83-133. Karger. Basel.
37. CUTLER, R.G. 1982. Longevity is determined by specific genes: testing the hypothesis. In Testing the Theories of Aging, pp. 25-114. CRC Press. Boca Raton, FL.
38. SASTRE, J., F.V. PALLARDO, J. GARCIA DE LA ASUNCION & J. VINA. 2000. Mitochondria, oxidative stress, and aging. Free Radical Res. 32(3): 189-198.
39. HOMMA, Y., M. TSUNODA & H. KASAI. 1994. Evidence for the accumulation of oxidative stress during cellular ageing of human diploid fibroblasts. Biochem. Biophys. Res. Commun. 203(2): 1063-1068.
40. HAMILTON, M.L., H. VAN REMMEN, J.A. DRAKE, et al. 2001. Does oxidative damage to DNA increase with age? Proc. Natl. Acad. Sci. USA 98(18): 10469-10474.
41. VAN REMMEN, H. & A. RICHARDSON. 2001. Oxidative damage to mitochondria and aging. Exp. Gerontol. 36(7): 957-968.
42. CUTLER, R.G. 1993. Oxidative stress state in aging and longevity mechanisms. In Free Radicals: From Basic Science to Medicine. Birkhauser. Basel/New York.
43. STADTMAN, E.R. & B.S. BERLETT. 1998. Reactive oxygen-mediated protein oxidation in aging and disease. Drug Metab. Rev. 30(2): 225-243.
44. FUKAGAWA, N.K. 1999. Aging: is oxidative stress a marker or is it causal? Proc. Soc. Exp. Biol. Med. 222(3): 293-298.
45. DAX, E.M., J.S. PARTILLA, M.A. PINEYRO & R.I. GREGERMAN. 1987. Beta-adrenergic receptors, glucagon receptors, and their relationship to adenylate cyclase in rat liver during aging. Endocrinology 120(4): 1534-1541.
46. ROTH, G.S. 1997. Age changes in signal transduction and gene expression. Mech. Ageing Dev. 98(3): 231-238.
47. ISHIKAWA, Y., M.V. GEE, B.J. BAUM & G.S. ROTH. 1989. Decreased signal transduction in rat parotid cell aggregates during aging is not due to loss of alpha 1-adrenergic receptors. Exp. Gerontol. 24(1): 25-36.
48. ROY, D., B. KALYANARAMAN & J.G. LIEHR. 1991. Xanthine oxidase-catalyzed reduction of estrogen quinones to semiquinones and hydroquinones. Biochem. Pharmacol. 42(8): 1627-1631.
49. GREGERMAN, R.I. 1986. Mechanisms of age-related alterations of hormone secretion and action: an overview of 30 years of progress. Exp. Gerontol. 21(4-5): 345-365.
50. TAMIR, A., M.D. EISENBRAUN, G.G. GARCIA & R.A. MILLER. 2000. Age-dependent alterations in the assembly of signal transduction complexes at the site of T cell/APC interaction. J. Immunol. 165(3): 1243-1251.
51. AWAD, A.B. & S.W. CLAY. 1982. Age-dependent alterations in lipids and function of rat heart sarcolemma. Mech. Ageing Dev. 19(4): 333-342.
52. YANAGAWA, K., H. TAKEDA, T. EGASHIRA, et al. 1999. Age-related changes in alpha-tocopherol dynamics with relation to lipid hydroperoxide content and fluidity of rat erythrocyte membrane. J. Gerontol. A Biol. Sci. Med. Sci. 54(9): B379-B383.
53. ANDO, K., M. BEPPU & K. KIKUGAWA. 1995. Evidence for accumulation of lipid hydroperoxides during the aging of human red blood cells in the circulation. Biol. Pharm. Bull. 18(5): 659-663.
54. HASHIMOTO, M., S. HOSSAIN & S. MASUMURA. 1999. Effect of aging on plasma membrane fluidity of rat aortic endothelial cells. Exp. Gerontol. 34(5): 687-698.
55. HOSSAIN, M.S., M. HASHIMOTO, S. GAMOH & S. MASUMURA. 1999. Association of age-related decrease in platelet membrane fluidity with platelet lipid peroxide. Life Sci. 64(2): 135-143.
56. SNYDER, P. J., H. PEACHEY, P. HANNOUSH, et al. 1999. Effect of testosterone treatment on bone mineral density in men over 65 years of age. J. Clin. Endocrinol. Metab. 84(6): 1966-1972.
57. SNYDER, P.J., H. PEACHEY, P. HANNOUSH, et al. 1999. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J. Clin. Endocrinol. Metab. 84(8): 2647-2653.
58. SIH, R., I.E. MORLEY, F.E. KAISER, et al. 1997. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J. Clin. Endocrinol. Metab. 82(6): 1661-1667.
59. HAJJAR, R.R., F.E. KAISER & J.E. MORLEY. 1997. Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis. J. Clin. Endocrinol. Metab. 82(11): 3793-3796.
60. KUNELIUS, P., O. LUKKARINEN, M.L. HANNUKSELA, et al. 2002. The effects of transdermal dihydrotestosterone in the aging male: a prospective, randomized, double blind study. J. Clin. Endocrinol. Metab. 87(4): 1467-1472.
61. BLACKMAN, M.R., J.D. SORKIN, T. MUNZER, et al. 2002. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA 288(18): 2282-2292.
62. WOMEN'S HEALTH INITIATIVE. 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288(3): 321-333.
63. GRODSTEIN, F., T.B. CLARKSON & J.E. MANSON. 2003. Understanding the divergent data on postmenopausal hormone therapy. N. Engl. J. Med. 348(7): 645-650.
64. HARMAN, S.M., E.J. METTER, M.R. BLACKMAN, et al. 2000. Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer. J. Clin. Endocrinol. Metab. 85(11): 4258-4265.
65. CHAN, J.M., M.J. STAMPFER, E. GIOVANNUCCI, et al. 1998. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study [see comments]. Science 279(5350): 563-566.
66. ROLF, C. & E. NIESCHLAG. 1998. Potential adverse effects of long-term testosterone therapy. Bailliere's Clin. Endocrinol. Metab. 12(3): 521-534.
67. BERGKVIST, L., H-O. ADAMI, I. PERSSON, et al. 1989. The risk of breast cancer after estrogen and estrogen-progestin replacement. N. Engl. J. Med. 321(5): 293-297.
68. SCHAIRER, C., J. LUBIN, R. TROISI, et al. 2000. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. J. Am. Med. Assoc. 283(4): 485-491.
69. DE GREY, A.D. 2002. Stem cells: a cellular fountain of youth. In Advances in Cell Aging and Gerontology. Elsevier. Amsterdam/New York.
70. VAN ZANT, G. 2003. Genetic control of stem cells: implications for aging. Int. J. Hematol. 77(1): 29-36.
71. TROSKO, J.E. 2003. Human stem cells as targets for the aging and diseases of aging processes. Med. Hypotheses 60(3): 439-447.
72. ROCCANOVA, L. & P. RAMPHAL. 2003. The role of stem cells in the evolution of longevity and its application to tissue therapy. Tissue Cell 35(1): 79-81.
73. CHEN, H., I. HUHTANIEMI & B.R. ZIRKIN. 1996. Depletion and repopulation of Leydig cells in the testes of aging brown Norway rats. Endocrinology 137(8): 3447-3452.
74. MILLS, D.E., W.R. GALEY & H. DIXON. 1993. Effects of dietary fatty-acid supplementation on fatty-acid composition and deformability of young and old erythrocytes. Biochim. Biophys. Acta 1149(2): 313-318.
75. HASHIMOTO, M., S. HOSSAIN, H. YAMASAKI, et al. 1999. Effects of eicosapentaenoic acid and docosahexaenoic acid on plasma membrane fluidity of aortic endothelial cells. Lipids 34(12): 1297-1304.
76. MCMURCHIE, E.J., B.M. MARGETTS, L.J. BEILIN, et al. 1984. Dietary-induced changes in the fatty acid composition of human cheek cell phospholipids: correlation with changes in the dietary polyunsaturated/saturated fat ratio. Am. J. Clin. Nutr. 39(6): 975-980.
77. STANGL, G.I., M. KIRCHGESSNER, K. EDER & A.M. REICHLMAYR-LAIS. 1994. Effect of dietary hyperlipidemic components and fish oil on concentration of lipids in liver and liver fatty acid profile of rats. Z. Ernaehrwiss. 33(3): 195-206.
78. AWAD, T.B. & J.P. CHATTOPADHYAY. 1983. Effect of dietary fats on the lipid composition and enzyme activities of rat cardiac sarcolemma. J. Nutr. 13(9): 1878-1883.
79. AWAD, A.B. 1981. Effect of dietary lipids on composition and glucose utilization by rat adipose tissue. J. Nutr. 111(1): 34-39.
80. PANEK, R.L., W.R. DIXON & C.O. RUTLEDGE. 1985. Modification of sympathetic neuronal function in the rat tail artery by dietary lipid treatment. J. Pharmacol. Exp. Ther. 233(3): 578-583.
81. TRIPODI, A., P. LORIA, M.A. DILENGITE & N. CARULLI. 1991. Effect of fish oil and coconut oil diet on the LDL receptor activity of rat liver plasma membranes. Biochim. Biophys. Acta 1083(3): 298-304.
82. SEMAFUKO, W.E., C.O. RUTLEDGE & W.R. DIXON, 1987. Effect of dietary lipids on myocardial norepinephrine content and field stimulation-mediated release of norepinephrine from perfused neonatal and adult rat hearts. J. Cardiovasc. Pharmacol. 10(1): 16-23.
83. GIRON, M.D., R. SALTO, P. HORTELANO, et al. 1999. Increased diaphragm expression of GLUT4 in control and streptozotocin-diabetic rats by fish oil-supplemented diets. Lipids 34(8): 801-807.
84. SOHAL, P.S., V.E. BARACOS & M.T. CLANDININ. 1992. Dietary omega 3 fatty acid alters prostaglandin synthesis, glucose transport, and protein turnover in skeletal muscle of healthy and diabetic rats. Biochem. J. 286(part 2): 405-411.
85. PEHOWICH, D.J. 1999. Thyroid hormone status and membrane n-3 fatty acid content influence mitochondrial proton leak. Biochim. Biophys. Acta 1411(1): 192-200.
86. PONNAPPAN, U., B. CINADER & M.T. CLANDININ. 1988. Effect of dietary fat on antibody response and on down-regulation. Immunol. Lett. 18(3): 205-211.
87. DAX, E.M., J.S. PARTILLA, M.A. PINEYRO & R.I. GREGERMAN. 1990. Altered glucagon-and catecholamine hormone-sensitive adenylyl cyclase responsiveness in rat liver membranes induced by manipulation of dietary fatty acid intake. Endocrinology 127(5): 2236-2240.
88. KOWATCH, M.A., J.F. KELLY, N.A. DENISOVA & G.S. ROTH. 1995. Partial restoration of impaired alpha1-adrenergic responsiveness in parotid cells of aged rats by S-adenosylmethionine treatment. Mol. Cell. Biochem. 148(1): 73-77.
89. MINEHIRA, K., S. INOUE, M. NONAKA, et al. 2000. Effects of dietary protein type on oxidized cholesterol-induced alteration in age-related modulation of lipid metabolism and indices of immune function in rats. Biochim. Biophys. Acta 1483(1): 141-153.
90. CINADER, B., M.T. CLANDININ, S.W. KOH, et al. 1986. Dietary fat alters progression of some age-related changes of the immune system. Immunol. Lett. 12(2-3): 175-179.
91. CINADER, B., M.T. CLANDININ, T. HOSOKAWA & N.M. ROBBLEE. 1983. Dietary fat alters the fatty acid composition of lymphocyte membranes and the rate at which suppressor capacity is lost. Immunol. Lett. 6(6): 331-337.
92. KEARNS, R.J., M.G. HAYEK, J.J. TUREK, et al. 1999. Effect of age, breed, and dietary omega-6 (n-6):omega-3 (n-3) fatty acid ratio on immune function, eicosanoid production, and lipid peroxidation in young and aged dogs. Vet. Immunol. Immunopathol. 69(2-4): 165-183.
93. MCGAHON, B.M., D.S. MARTIN, D.F. HORROBIN & M.A. LYNCH. 1999. Age-related changes in synaptic function: analysis of the effect of dietary supplementation with omega-3 fatty acids. Neuroscience 94(1): 305-314.
94. LUO, J., S.W. RIZKALLA, H. VIDAL, et al. 1998. Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men: results of a controlled study. Diabetes Care 21(5): 717-724.
95. MORI, T.A., R. VANDONGEN, J.R. MASAREI, et al. 1991. Comparison of diets supplemented with fish oil or olive oil on plasma lipoproteins in insulin-dependent diabetics. Metabolism 40(3): 241-246.
96. RIVELLESE, A.A., A. MAFFETTONE, C. IOVINE, et al. 1996. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia. Diabetes Care 19(11): 1207-1213.
97. MCVEIGH, G.E., G.M. BRENNAN, J.N. COHN, et al. 1994. Fish oil improves arterial compliance in non-insulin-dependent diabetes mellitus. Arterioscler. Thromb. 14(9): 1425-1429.
98. TOFT, I., K.H. BONAA, O.C. INGEBRETSEN, et al. 1997. Fibrinolytic function after dietary supplementation with omega-3 polyunsaturated fatty acids. Arterioscler. Thromb. Vasc. Biol. 17(5): 814-819.
99. PERSICHETTI, S., S. MAGGI, R. PONZIO, et al. 1996. Effects of omega-3 PUFA on plasma fibrinogen levels in hypertriglyceridemic hemodialysis patients. Minerva Urol. Nefrol. 48(3): 137-138.
100. STONE, N.J. 2000. The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardio (GlSSI)-Prevenzione Trial on fish oil and vitamin E supplementation in myocardial infarction survivors. Curr. Cardiol. Rep. 2(5): 445-451.
101. ALBERT, C.M., C.H. HENNEKENS, C.J. O'DONNELL, et al 1998. Fish consumption and risk of sudden cardiac death [see comments]. JAMA 279(1): 23-28.
102. MORRIS, J.Z., H.A. TISSENBAUM & G. RUVKUN. 1996. A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans. Nature 382(6591): 536-539.
103. SHEARD, N.F. 1998. Fish consumption and risk of sudden cardiac death. Nutr. Rev. 56(6): 177-179.
104. CHRISTENSEN, J.H., J. AAROE, N. KNUDSEN, et al. 1998. Heart rate variability and n-3 fatty acids in patients with chronic renal failure - a pilot study. Clin. Nephrol. 49(2): 102-106.
105. MAES, M., A. CHRISTOPHE, J. DELANGHE, et al. 1999. Lowered omega-3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res. 85(3): 275-291.
106. KALMIJN, S., E.J. FESKENS, L.J. LAUNER & D. KROMHOUT. 1997. Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am. J. Epidemiol. 145(1): 33-41.
107. GIBSON, R.A., M.A. NEUMANN & M. MAKRIDES. 1996. Effect of dietary docosahexanoic acid on brain composition and neural function in term infants. Lipids 31(suppl.): 177-181.
108. STORLIEN, L.H., A.D. KRIKETOS, A.B. JENKINS, et al. 1997. Does dietary fat influence insulin action? Ann. N.Y. Acad. Sci. 827: 287-301.
109. FESKENS, E.J., C.H. BOWLES & D. KROMHOUT. 1991. Inverse association between fish intake and risk of glucose intolerance in normoglycemic elderly men and women. Diabetes Care 14(11): 935-941.